Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Agence Bibliographique de l Enseignement Superieur (ABES)

Citation Tools

XML

Research

Ophthalmology

Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Bourne RRA, Kaarniranta K, Lorenz K, et al

Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study

BMJ Open 2019;9:e024129. doi: 10.1136/bmjopen-2018-024129